HAI Therapy by Boston Scientific

03/17/2026

What’s being missed when colorectal cancer spreads to the liver?

Too often, patients with colorectal liver metastases (CRLM) are not evaluated by a surgeon.

Liver-directed treatment or surgery could be options. But without a surgeon’s input, those options may not be explored.

That’s why the Alliance is shining a light on more treatment options in CRLM care, in collaboration with Boston Scientific.
Seeing a surgeon may help you see what’s possible.

Have questions about your options? Our Cancer Care Team is here to help. Call our free helpline at 877-422-2030.

03/06/2026

Intera Oncology is now part of Boston Scientific.

Boston Scientific will continue supporting the Intera 3000 Hepatic Artery Infusion (HAI) Pump while advancing care for people living with cancer in the liver.

Thank you to the patients, caregivers, and clinicians who are part of our community. As of today, this page will officially transition to HAI therapy by Boston Scientific.

08/14/2025

After a diagnosis of Stage 4 with liver metastases 16 years ago, Pete was ready to fight, and a second opinion led him to treatment with . Read his firsthand account in Conquer: the journey informed: https://ampmed.site/tCDYecwp

When Peter Beckerman was told he had less than 2 years to live, he refused to accept it. Read his inspiring story of resilience, second opinions, and the innovative treatment that helped him defy the odds and live to tell the tale.

08/05/2025

If you're navigating stage IV colorectal cancer, especially with liver metastases, this is a conversation you won't want to miss.

Tomorrow, August 6 at 12pm CT at 1pm ET, Memorial Sloan Kettering Cancer Center oncologist Dr. Louise Connell and stage IV colorectal cancer survivor Carole Motycka will talk us through liver metastasis, colorectal cancer, and HAI pump therapy—a unique treatment option that might apply to you.

Bring your questions and join us for this informative, patient-centered discussion!

Register here: https://fightcrc.zoom.us/webinar/register/WN_9Is6nUnqSEidme5mmhiuog

Thank you, Intera Oncology, Inc. for supporting this educational webinar! 💙

08/04/2025

At the Colorectal Cancer Alliance, we’re proud to partner with Intera Oncology, Inc. to ensure that patients diagnosed with stage IV colorectal cancer with liver metastases get timely, expert information about their treatment options — including HAI therapy. 💙

Through a direct navigator-to-navigator referral process, our clinical navigator collaborates closely with Intera’s patient navigator to support individuals and families with personalized, compassionate care. This partnership helps connect patients to specialized resources when it matters most.

If you or a loved one needs support with your diagnosis, call our free Helpline at 877-422-2030. We’re here to help. 💙

06/27/2025

is a liver-directed treatment for that has spread to the liver and intrahepatic . Find out how it works: https://bit.ly/48wWlAH

06/13/2025

If you have that has spread to the liver or within the liver, may be a treatment option for you. Find out more: https://bit.ly/493PHBU

05/30/2025

For patients with unresectable intrahepatic with high tumor burden and no/limited extrahepatic disease, may be a powerful option. Discover the impact of HAI therapy: https://bit.ly/4cqdEpe

05/23/2025

Want to learn more about ? Explore our patient resource library: https://bit.ly/3BjH7U4

05/16/2025

Recent data showed patients with unresectable intrahepatic achieved 21% 5-year survival following HAI therapy. Read the study: https://bit.ly/3Gk1HWP

05/08/2025

Oncology nurses are essential members of the team. This week, and every week, we celebrate your invaluable contributions to patient care.

, , ,

05/02/2025

For patients with metastatic with large or multi-focal tumors confined to the liver, may be a powerful option. Learn more and connect with an HAI expert: https://bit.ly/4anOiIk